REQUEST A DEMO
Total
USD $0.00
Search more companies

Bora Pharmaceuticals Co., Ltd. (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Bora Pharmaceuticals Co., Ltd. Profile Updated: March 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Bora Pharmaceuticals Co., Ltd. is a company in Taiwan, China, with a head office in Taipei City. The company operates in the Pharmaceutical and Medicine Manufacturing sector. Bora Pharmaceuticals Co., Ltd. was incorporated on June 12, 2007. The total number of employees is currently 905 (2023). From the latest financial highlights, Bora Pharmaceuticals Co., Ltd. reported a net sales revenue increase of 35.31% in 2023. Its’ total assets recorded a growth of 10.06%. The enterprise’s net profit margin increased by 8.28% in 2023.

Headquarters
6F., No. 2, Aly. 36, Ln. 26, Ruiguang Rd, Neihu Dist
Taipei City; Taipei City;

Contact Details: Purchase the Bora Pharmaceuticals Co., Ltd. report to view the information.

Website: http://www.bora-corp.com/

Basic Information
Total Employees:
Purchase the Bora Pharmaceuticals Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Bora Pharmaceuticals Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Bora Pharmaceuticals Co., Ltd. report to view the information.
Incorporation Date:
June 12, 2007
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Vice President
Ownership Details
Purchase this report to view the information.
18.53%
Purchase this report to view the information.
5.31%
Purchase this report to view the information.
3.86%
Purchase this report to view the information.
1.19%
Purchase this report to view the information.
Subsidiaries
Bora Pharmaceuticals Usa Inc (United States)
100%
Bora Pharmaceutical Services I (Canada)
50%
Company Performance
Financial values in the chart are available after Bora Pharmaceuticals Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
35.31%
Total operating revenue
35.6%
Operating profit (EBIT)
120.58%
EBITDA
158.84%
Net Profit (Loss) for the Period
119.18%
Total assets
10.06%
Total equity
128.89%
Operating Profit Margin (ROS)
11.54%
Net Profit Margin
8.28%
Return on Equity (ROE)
-1.15%
Debt to Equity Ratio
-91.52%
Quick Ratio
0.05%
Cash Ratio
0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?